Top compounds associated with response to RP11-106M3.2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Doxorubicin	CTRPv2	pan-cancer	AAC	-0.17	6e-08
mRNA	Cytarabine	CTRPv2	pan-cancer	AAC	-0.16	1e-07
mRNA	GSK461364	CTRPv2	pan-cancer	AAC	-0.17	3e-07
mRNA	3-Cl-AHPC	CTRPv2	pan-cancer	AAC	-0.18	6e-07
mRNA	Topotecan	CTRPv2	pan-cancer	AAC	-0.16	1e-06
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.16	1e-06
mRNA	navitoclax:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.17	1e-06
mRNA	SNX-2112:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.16	1e-06
mRNA	SN-38	CTRPv2	pan-cancer	AAC	-0.18	2e-06
mRNA	Teniposide	CTRPv2	pan-cancer	AAC	-0.19	3e-06

Download CSV